No­vo un­veils new car­diometa­bol­ic da­ta as it re­ports sol­id third-quar­ter prof­its

No­vo Nordisk dis­closed sev­er­al key up­dates from its car­diometa­bol­ic and hema­tol­ogy pipelines Wednes­day as the drug­mak­er re­vealed its third-quar­ter prof­its edged out ex­pec­ta­tions.

First up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER